UniSuper Management’s AbbVie ABBV Stock Holding History

UniSuper Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$93.1M	Buy	369,817 +88,673	+32%	+$19.1M	0.48%	43
2026 Q1	$61.1M	Buy	281,144 +27,941	+11%	+$6.2M	0.4%	54
2025 Q4	$57.9M	Buy	253,203 +1,809	+0.7%	+$412K	0.35%	61
2025 Q3	$58.2M	Buy	251,394 +21,547	+9%	+$4.39M	0.36%	58
2025 Q2	$42.7M	Sell	229,847 -2,761	-1%	-$513K	0.29%	77
2025 Q1	$48.7M	Buy	232,608 +133,172	+134%	+$25.9M	0.36%	56
2024 Q4	$17.7M	Buy	99,436 +15,690	+19%	+$2.88M	0.13%	118
2024 Q3	$16.5M	Buy	83,746 +3,543	+4%	+$661K	0.12%	124
2024 Q2	$13.8M	Buy	80,203 +50,273	+168%	+$8.33M	0.11%	126
2024 Q1	$5.45M	Sell	29,930 -127,666	-81%	-$22M	0.05%	171
2023 Q4	$24.4M	Sell	157,596 -16,284	-9%	-$2.37M	0.27%	87
2023 Q3	$25.9M	Buy	173,880 +12,089	+7%	+$1.77M	0.32%	77
2023 Q2	$21.8M	Buy	+161,791	New	+$23.7M	0.25%	86

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UniSuper Management's ABBV Position: Q2 2026 in Review

UniSuper Management increased its AbbVie (ABBV) stake by 32% in Q2 2026, buying an estimated $19.1M and bringing the position to 369,817 shares worth $93.1M. The position accounts for 0.48% of the portfolio, ranked #43.

UniSuper Management first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

UniSuper Management held 369,817 shares of AbbVie worth $93.1M as of Q2 2026.
UniSuper Management bought 88,673 AbbVie shares in Q2 2026, an estimated $19.1M.
AbbVie made up 0.48% of UniSuper Management's portfolio in Q2 2026, its #43 holding.
UniSuper Management first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.